>
Organization
Celgene Corp.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Celgene Corp.

... Celgene has announced positive new data for its leading blockbuster drug, Revlimid (lenalidomide), ...
... and early development at Nimbus Therapeutics, a position he also held at Celgene and Avila Therapeutics, working on first-in-human programs and clinical proof-of-concept studies. He ...
... in heavily pre-treated ovarian cancer patients to date Ongoing collaboration with Celgene Corporation ('Celgene') with an option to license OncoMed's etigilimab (anti-TIGIT) program A strong ...
... & Co., Inc., Hoffmann-La Roche AG., Teva Pharmaceuticals Industries Limited, Novartis AG, CELGENE CORPORATION, Sanofi S.A., JOHNSON & JOHNSON, AMAG Pharmaceuticals and Shire plc., among ...
... mainly include Siponimod (BAF312; Novartis), Ponesimod (ACT-128800; Johnson and Johnson), Ozanimod (RPC1063; Celgene), Ofatumumab (Novartis), Ublituximab (TG Therapeutics), ALKS 8700 (Alkermes Plc), Gocovri (Adamas Pharmaceuticals), ...
... said Chris Bowden, M.D., chief medical officer at Agios. 'In conjunction with Celgene, we will provide support of the Phase 3 HOVON 150 AML/AMLSG 29-18 ...
... can be no guarantee that any product candidate Agios or its collaborator, Celgene, is developing will successfully commence or complete necessary preclinical and clinical development ...
... Celgene Corporation (NASDAQ:CELG) today announced initial safety data from its ongoing proof-of-concept trial of ...
... SUMMIT - Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results ...
... started to decrease. Yesterday, it also presented the first data on its Celgene-partnered anti-BCMA adoptive cell therapy bb21217, showing the CAR-T achieved an objective response ...
Subscribe now for full coverage on Celgene Corp.
Start My Free Trial